Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIP | P01282 | 2/20 | 0.49 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.48 |
| ▸ | SCN3A | Q9NY46 | 4/20 | 0.48 |
| ▸ | KCNA6 | P17658 | 1/20 | 0.42 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.42 |
| ▸ | KCNA4 | P22459 | 1/20 | 0.42 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.42 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | CBLB | Q13191 | 4/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | SCN4A | P35499 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12559790 | 0.94 | VIP (0.54) | VIPSCN9ASCN3AKCNA6KCNA3 | |
| SCHEMBL12597859 | 0.94 | VIP (0.54) | VIPSCN9ASCN3AKCNA6KCNA3 | |
| SCHEMBL12855200 | 0.94 | VIP (0.40) | VIPSCN9ASCN3AKCNA6KCNA3 | |
| SCHEMBL12852200 | 0.94 | VIP (0.54) | VIPSCN9ASCN3AKCNA6KCNA3 | |
| SCHEMBL12598740 | 0.84 | VIP (0.45) | VIPSCN9ASCN3AKCNA6KCNA3 | |
| SCHEMBL12598739 | 0.81 | SCN9A (0.43) | VIPSCN9ASCN3AKCNA6KCNA3 | |
| SCHEMBL12852189 | 0.79 | SCN9A (0.53) | SCN9ASCN3AKCNA6KCNA3KCNA4 | |
| SCHEMBL12559784 | 0.79 | SCN9A (0.53) | SCN9ASCN3AKCNA6KCNA3KCNA4 | |
| SCHEMBL14328328 | 0.78 | SCN9A (0.48) | SCN9ASCN3AKCNA6KCNA3KCNA4 | |
| SCHEMBL13803868 | 0.76 | SCN9A (0.47) | SCN9ASCN3AKCNA6KCNA3KCNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8278340-B2 | Inhibition of biofilms in plants with imidazole derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-10-02 | — | — | US | disclosed |
| US-20090143230-A1 | INHIBITION OF BIOFILMS IN PLANTS WITH IMIDAZOLE DERIVATIVES | NORTH CAROLINA STATE UNIVERSITY (US) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143230-A1 | INHIBITION OF BIOFILMS IN PLANTS WITH IMIDAZOLE DERIVATIVES | ITPA, SOD1, ICMT | VIP 394/4885SCN9A 1732/4885SCN3A 3664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.